Project Gamma: $1.3M Adj. EBITDA In-Network Outpatient Diagnostic Imaging Service Provider

0  comments

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Gamma (the “Companies”), a portfolio of ACR accredited, diagnostic imaging centers.  The Companies, through their 4 centers, have been providing advanced medical imaging services in South Florida for over 30 years. Utilizing state-of-the-art technology, the Companies offer a comprehensive range of imaging modalities, including biopsy, computed tomography, magnetic resonance imaging, 3D mammography, nuclear medicine, PET/CT scans, ultrasound, and more.

From 2022 to 2024, the Companies have provided services to an average of 39,000 patients annually and are in-network with over 35 insurance companies. With over 50 employees and a 9K+ physician referral base, the Companies are well positioned for continued growth.

Financial Overview

 

 2023  2024
 Revenue  8.2M  8.8M
 Gross Profit  5.1M  5.7M
 Adjusted EBITDA  .3M  1.3M
 EBITDA Margin  3%  15%

 

Our clients, the ownership group, have retained MAHA to explore a transaction. Management and ownership are open to evaluating their roles and responsibilities post-transaction. If you would like to learn more about Project Gamma, please sign our NDA via the link below.

Tags


Get in touch

Name*
Email*
Message
0 of 350